Bob White joined EW as an Operating Partner in 2019 after nearly 30 years leading early-stage companies and Fortune 500 business units in the medical technology sector, including most recently as President and CEO of Entellus Medical, an EW portfolio company acquired by Stryker.
Mr. White has played an important role in furthering EW’s medical device investment practice. He served on the Board of Directors for Cardiva Medical before it was acquired by Haemonetics, currently serves as the Executive Chairman of the Board of TissueTech and on the Board of Directors for Vital Connect.
As mentioned, prior to EW Mr. White was President and Chief Executive Officer of Entellus Medical, driving the business to treat over 250,000 patients suffering from chronic sinusitis, Eustachian tube dysfunction and airway obstruction. In 2018 Mr. White was recognized as a finalist of the Ernst & Young Entrepreneur of the Year and he received the YPO Global Innovation Award.
Prior to Entellus, Mr. White was the President and Chief Executive Officer of TYRX, Inc. which specialized in commercializing innovative, implantable combination drug and device products focused on infection control until TYRX was acquired by Medtronic in 2014. Along the way, in 2012, TYRX was named to the Fierce Medical Devices “Fierce 15”, designating it as one of the leading medical device and diagnostic companies.
Before joining TYRX, Mr. White held several executive positions with Medtronic including serving as President of Physio Control, Vice President of Commercial Operations of the Cardiac Rhythm Disease Management business, and President of Kyphon following Medtronic’s acquisition of the spinal treatment business. Earlier in his career, he held leadership positions in business development, international sales and marketing, operations, and general management with Instromedix/Life Watch, Eli Lilly, IVAC/Alaris Medical, and General Electric.
Mr. White currently also serves as a Director on the Board of Atricure Inc. (NASDAQ: ATRC) and Director on the Board of privately held Cardiac Dimensions Pty. Ltd. Two other companies for which he actively served as a Director were acquired for significant premiums including Novadaq Technologies and privately held Hyperbranch Medical Technology.
Mr. White holds a Bachelor of Science degree in Aerospace Engineering from the University of Missouri-Rolla and a Master of Business Administration degree from Cornell University.